Oct 16, 2026 06:20AM
Oct 16, 2026 06:19AM
Aug 12, 2026 04:02PM
Aug 10, 2026 08:00AM
Aug 3, 2026 08:32AM
Aug 3, 2026 08:30AM
Jun 26, 2026 08:30AM EMA panel issues negative opinion on Omeros narsoplimab application
Jun 26, 2026 08:30AM
Jun 15, 2026 08:30AM
May 13, 2026 04:02PM
May 11, 2026 04:02PM
Apr 16, 2026 08:50AM
Apr 16, 2026 08:45AM
Mar 31, 2026 04:02PM Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
Mar 26, 2026 08:45AM
Mar 21, 2026 03:23AM
Feb 17, 2026 08:45AM
Jan 27, 2026 09:02AM
Jan 27, 2026 09:00AM
Dec 29, 2025 05:11AM
Dec 26, 2025 06:36PM Omeros Announces New Date for YARTEMLEA® Approval Conference Call
Dec 24, 2025 10:40AM
Dec 24, 2025 09:00AM
Dec 24, 2025 09:00AM
Dec 1, 2025 08:30AM
Dec 1, 2025 08:30AM
Nov 13, 2025 04:11PM
Nov 11, 2025 08:30AM Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025
Oct 16, 2025 08:33AM
Oct 16, 2025 08:30AM
Oct 15, 2025 08:30AM
Sep 2, 2025 08:45AM
Sep 2, 2025 08:45AM
Aug 14, 2025 04:02PM
Aug 11, 2025 04:02PM Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025
Jul 25, 2025 08:00AM
Jul 25, 2025 08:00AM
Jun 27, 2025 08:31AM
Jun 27, 2025 08:30AM
Jun 24, 2025 08:30AM
May 15, 2025 04:05PM
May 12, 2025 05:05PM Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
May 12, 2025 08:41AM
May 12, 2025 08:41AM
May 6, 2025 09:16AM
May 6, 2025 09:16AM
Apr 10, 2025 09:10AM
Apr 10, 2025 09:10AM
Apr 8, 2025 09:00AM Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases
Mar 31, 2025 04:02PM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All